Relenza

Medicinal product

(Invented) name

Relenza

Active substance (s)

Zanamiviras

Strength

5 mg/dozėje

Pharmaceutical form

dozuoti įkvepiamieji milteliai

Route (s) of administration

įkvėpti

Legal status for supply

Receptinis

Narrow therapeutic index (NTI)

No

ATC code (s)

J05AH01, Zanamivir

Marketing authorisation holder

UAB Niromed, Lietuva

Date of authorisation

2025-06-20

Date of renewal

Documents

2655_Relenza 5mg N5_PZ.docx

2655_Relenza 5mg N5_PIL.docx

Stage

Registruotas

Controlled?

No

Controlled substance type

Legal basis

Procedure number

Marketing authorisation procedure

Lygiagretus importas

Qualitative and quantitative composition

Dozėje yra:	1 dozėje
Zanamiviras	5 mg

Packages

PAKID	NPAKID	NPAKID-7	Pack type	Pack size	Type of packaging	Proposed dispensing/classification	Marketing authorisation no.	Supply status	From	To	Package is in foreign language	From	To	Mock-up
117868	103973	1103973	lizdinė plokštelė	diskas (4 dozės) N5 ir inhaliatorius		Receptinis	LT/L/25/2655/001	Netiekiama	-	2025-11-30	Yes	2025-09-22	2025-11-30	Download

Stadijos

Data	Stadija
2025-06-20	Registruotas